This Viewpoint discusses factors that play a role in the low rate of lipid screening in children, including a lack of compelling evidence, disagreement with recommendations, and concerns for overdiagnosis and overtreatment. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Intimate Partner Violence and Parenting Clinical Practice Guidelines Machine Learning and Statistics in Clinical Research—Bridging the Gap Clinical Practice Guidelines Transgender Adolescent School Climate, Mental Health, and Adult Social Support Clinical Practice Guidelines Contraception Choice Beyond Efficacy—Reply Clinical Practice Guidelines Childhood Housing Insecurity and Anxiety and Depression Symptoms During Childhood and Adulthood Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.